Veru Gross Margin 2010-2023 | VERU
Current and historical gross margin for Veru (VERU) over the last 10 years. The current gross profit margin for Veru as of December 31, 2023 is %.
| Veru Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $0.02B | $0.01B | 50.00% |
| 2023-09-30 | $0.02B | $0.01B | 47.06% |
| 2023-06-30 | $0.02B | $0.01B | 43.75% |
| 2023-03-31 | $0.02B | $0.01B | 56.52% |
| 2022-12-31 | $0.03B | $0.02B | 68.97% |
| 2022-09-30 | $0.04B | $0.03B | 77.50% |
| 2022-06-30 | $0.05B | $0.04B | 79.25% |
| 2022-03-31 | $0.06B | $0.05B | 80.33% |
| 2021-12-31 | $0.06B | $0.05B | 80.33% |
| 2021-09-30 | $0.06B | $0.05B | 77.42% |
| 2021-06-30 | $0.06B | $0.05B | 79.31% |
| 2021-03-31 | $0.05B | $0.04B | 78.00% |
| 2020-12-31 | $0.05B | $0.04B | 74.47% |
| 2020-09-30 | $0.04B | $0.03B | 72.09% |
| 2020-06-30 | $0.04B | $0.03B | 67.50% |
| 2020-03-31 | $0.04B | $0.03B | 67.50% |
| 2019-12-31 | $0.04B | $0.03B | 67.57% |
| 2019-09-30 | $0.03B | $0.02B | 71.88% |
| 2019-06-30 | $0.03B | $0.02B | 71.43% |
| 2019-03-31 | $0.02B | $0.02B | 66.67% |
| 2018-12-31 | $0.02B | $0.01B | 60.00% |
| 2018-09-30 | $0.02B | $0.01B | 47.06% |
| 2018-06-30 | $0.02B | $0.01B | 43.75% |
| 2018-03-31 | $0.01B | $0.01B | 42.86% |
| 2017-12-31 | $0.01B | $0.01B | 46.15% |
| 2017-09-30 | $0.01B | $0.01B | 53.85% |
| 2017-06-30 | $0.01B | $0.01B | 53.85% |
| 2017-03-31 | $0.02B | $0.01B | 53.33% |
| 2016-12-31 | $0.02B | $0.01B | 55.56% |
| 2016-09-30 | $0.02B | $0.01B | 56.52% |
| 2016-06-30 | $0.03B | $0.02B | 57.69% |
| 2016-03-31 | $0.03B | $0.02B | 60.71% |
| 2015-12-31 | $0.03B | $0.02B | 58.82% |
| 2015-09-30 | $0.03B | $0.02B | 57.58% |
| 2015-06-30 | $0.03B | $0.02B | 56.25% |
| 2015-03-31 | $0.03B | $0.02B | 53.13% |
| 2014-12-31 | $0.03B | $0.01B | 52.00% |
| 2014-09-30 | $0.03B | $0.01B | 52.00% |
| 2014-06-30 | $0.02B | $0.01B | 50.00% |
| 2014-03-31 | $0.02B | $0.01B | 52.17% |
| 2013-12-31 | $0.03B | $0.02B | 57.14% |
| 2013-09-30 | $0.03B | $0.02B | 58.06% |
| 2013-06-30 | $0.04B | $0.02B | 61.11% |
| 2013-03-31 | $0.04B | $0.02B | 60.53% |
| 2012-12-31 | $0.04B | $0.02B | 59.46% |
| 2012-09-30 | $0.04B | $0.02B | 58.33% |
| 2012-06-30 | $0.03B | $0.02B | 57.58% |
| 2012-03-31 | $0.03B | $0.02B | 57.14% |
| 2011-12-31 | $0.02B | $0.01B | 54.17% |
| 2011-09-30 | $0.02B | $0.01B | 52.63% |
| 2011-06-30 | $0.02B | $0.01B | 55.00% |
| 2011-03-31 | $0.02B | $0.01B | 55.56% |
| 2010-12-31 | $0.02B | $0.01B | 57.14% |
| 2010-09-30 | $0.02B | $0.01B | 59.09% |
| 2010-06-30 | $0.02B | $0.01B | 54.55% |
| 2010-03-31 | $0.03B | $0.01B | 51.85% |
| 2009-12-31 | $0.03B | $0.01B | 51.85% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.177B | $0.016B |
| Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $185.422B | 24.34 |
| Stryker (SYK) | United States | $128.275B | 31.81 |
| Boston Scientific (BSX) | United States | $107.479B | 34.23 |
| Medtronic (MDT) | Ireland | $105.230B | 14.90 |
| EssilorLuxottica (ESLOY) | France | $98.467B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.075B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.356B | 30.00 |
| ResMed (RMD) | United States | $26.979B | 25.30 |
| Terumo (TRUMY) | Japan | $24.775B | 34.99 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.604B | 15.84 |
| Baxter (BAX) | United States | $20.430B | 14.90 |
| Koninklijke Philips (PHG) | Netherlands | $19.242B | 15.35 |
| Insulet (PODD) | United States | $11.496B | 60.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.440B | 0.00 |
| Demant (WILYY) | Denmark | $9.943B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.860B | 23.42 |
| BellRing Brands (BRBR) | United States | $7.238B | 38.92 |
| Lantheus Holdings (LNTH) | United States | $4.470B | 11.54 |
| Haemonetics (HAE) | United States | $4.452B | 22.77 |
| Perrigo (PRGO) | Ireland | $4.238B | 12.12 |
| GN Store Nord (GNNDY) | Denmark | $3.889B | 25.18 |
| Prestige Consumer Healthcare (PBH) | United States | $3.482B | 16.47 |
| Envista Holdings (NVST) | United States | $3.441B | 13.09 |
| QuidelOrtho (QDEL) | United States | $2.654B | 9.63 |
| Neogen (NEOG) | United States | $2.591B | 24.92 |
| Green Thumb Industries (GTBIF) | United States | $2.482B | 78.67 |
| ICU Medical (ICUI) | United States | $2.303B | 17.19 |
| TG Therapeutics (TGTX) | United States | $2.150B | 695.50 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.906B | 0.00 |
| Owens & Minor (OMI) | United States | $1.848B | 17.74 |
| Agios Pharmaceuticals (AGIO) | United States | $1.780B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.617B | 0.00 |
| InMode (INMD) | Israel | $1.429B | 7.40 |
| LeMaitre Vascular (LMAT) | United States | $1.414B | 46.66 |
| National Vision Holdings (EYE) | United States | $1.399B | 43.58 |
| AdaptHealth (AHCO) | United States | $1.273B | 9.58 |
| Warby Parker (WRBY) | United States | $1.254B | 0.00 |
| AtriCure (ATRC) | United States | $1.094B | 0.00 |
| MacroGenics (MGNX) | United States | $0.899B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.872B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.764B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.686B | 14.82 |
| Cresco Labs (CRLBF) | United States | $0.674B | 0.00 |
| Evolus (EOLS) | United States | $0.664B | 0.00 |
| Jin Medical (ZJYL) | China | $0.608B | 0.00 |
| Quanterix (QTRX) | United States | $0.596B | 0.00 |
| Valneva SE (VALN) | France | $0.526B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.504B | 10.91 |
| PetIQ (PETQ) | United States | $0.480B | 17.93 |
| TerrAscend (TSNDF) | Canada | $0.462B | 0.00 |
| ZimVie (ZIMV) | United States | $0.421B | 25.80 |
| Biote (BTMD) | United States | $0.416B | 3.96 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.66 |
| Surmodics (SRDX) | United States | $0.373B | 40.26 |
| Aurora Cannabis (ACB) | Canada | $0.366B | 0.00 |
| Zynex (ZYXI) | United States | $0.352B | 40.52 |
| Viemed Healthcare (VMD) | United States | $0.310B | 30.81 |
| Cerus (CERS) | United States | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.266B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.238B | 14.73 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.178B | 0.00 |
| Omeros (OMER) | United States | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| High Tide (HITI) | Canada | $0.161B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.156B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.141B | 70.99 |
| FitLife Brands (FTLF) | United States | $0.129B | 20.74 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| InterCure (INCR) | Israel | $0.120B | 20.31 |
| Fonar (FONR) | United States | $0.107B | 9.16 |
| MariMed (MRMD) | United States | $0.100B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
| Safety Shot (SHOT) | United States | $0.082B | 0.00 |
| Brainsway (BWAY) | Israel | $0.080B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.059B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.59 |
| Apyx Medical (APYX) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.95 |
| Bright Green (BGXX) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.019B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 74.09 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |